Managed Healthcare Executive

FDA Approves First Subcutaneous Version of Keytruda for Adults With Most Solid Tumors

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster ...
SurvivorNet on MSN

FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...
BioSpace

As Exclusivity Loss Looms, Merck Wins Subcutaneous Approval for Keytruda

For the last two years, Keytruda has reigned as the world’s top-selling drug—a distinction under threat with key patent ...
Healio

Continuous subcutaneous infusion linked to more ‘on’ time in Parkinson’s

Please provide your email address to receive an email when new articles are posted on . The study examined efficacy of subcutaneous vs. oral administration of carbidopa/levodopa. Subcutaneous infusion ...
Fierce Pharma

Merck scores FDA approval for subcutaneous Keytruda, securing potential blockbuster protection

While the test was conducted in NSCLC, the FDA approval includes existing solid tumor indications for Keytruda. Merck is ...
Healio

Cutaquig enables modified subcutaneous immunoglobulin infusion regimens

SAN ANTONIO — Cutaquig provided safe and effective dosing flexibility for patients with primary immunodeficiency disease, according to data presented at the American Academy of Allergy, Asthma & ...
Business Wire

Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete Suppression of Brain Lesions

– Late-breaking Phase III results show subcutaneous injection was non-inferior to intravenous infusion based on Ocrevus levels in the blood over 12 weeks – – Ocrevus subcutaneous injection was ...
MedPage Today

Subcutaneous Ocrelizumab Not Inferior to IV Infusion

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window MILAN -- An ...
pharmaphorum

FDA clears subcutaneous Keytruda in a boost to MSD

The FDA has cleared the new version for across most of the solid tumour indications already granted for Keytruda, which is ...
Managed Healthcare Executive

FDA Approves Subcutaneous Induction of Tremfya for Ulcerative Colitis Patients

Tremfya is now the first and only fully subcutaneous IL-23 inhibitor approved to treat both ulcerative colitis and Crohn’s ...
FierceBiotech

Unilife Develops Proprietary Portfolio of Wearable Subcutaneous Infusion Devices for the Self-Administration of Large Volume Dru

--The world's first and only wearable, disposable automatic delivery system for self-administration of drugs with dose volumes 5mL or larger --Now available to pharmaceutical companies for use in drug ...